Nitric oxide synthase induction with renal transplant rejection or infection. Nitric oxide (NO) is readily oxidized to nitrate and nitrite and NO activates guanylyl cyclase, increasing cyclic GMP levels. To determine if nitric oxide synthase (NOS) is present in urine collected daily from patients following renal transplantation, we evaluated NOS activity in the leukocyte-rich particulate fraction and measured nitrate, nitrite, and cyclic GMP levels in the supernatant fraction of the urine. Reverse transcriptase-PCR and eDNA sequencing confirmed the presence of inducible NOS (iNOS) in cells obtained from the urine of renal transplant patients with rejection. NOS activity was elevated significantly in renal transplant patients with rejection (6.40
directly from patients with any form of allograft transplant rejection. The purpose of the present study is to examine the changes in NOS activity and NOS-mRNA expression in urinary cells isolated from renal transplant patients with rejection or infection. Following the time course of NOS activity in renal transplantation patients, we find an acute increase in NOS activity, not only its by-products, occurring prior to the clinical diagnosis of rejection and a significant rise of NOS activity when renal transplantation is accompanied by a UTI.
Methods
Patient population A total of 25 renal transplant recipients at the Yale-New Haven Hospital were evaluated. The average age of the patients (13 males and 12 females) was 45.1 2.5 years (range 19 to 68 years).
Eleven patients had cadaveric renal transplantations and 14 had living-related transplantations. Ten transplant recipients had an episode of acute renal graft rejection (defined by a rising serum creatinine and confirming histopathology as determined by allograft biopsy) that responded to pulse corticosteroids or to OKT3. All primary urinary samples obtained from patients diagnosed with acute transplant rejection had at least 3 white blood cells! high power field and 90% of the patients had more than 3 white blood cells/high power field. Eight of the transplant recipients were diagnosed to have UTIs (UTI is defined as significant urinary bacteriuria, greater than 100,000 CFU/ml of a predominating microorganism). Of the patients with complications after renal transplantation, one patient was diagnosed with an intestinal perforation and transplant rejection and one was diagnosed with a urine leak and a UTI.
Urine sample isolation
Urine samples were collected from the following groups of hospitalized patients: (1) patients with chronic renal failure who had not undergone renal transplantation; (2) post-renal transplant patients without infection or rejection and with decreasing or stable serum creatinine (Cr) levels (controls); (3) renal transplant patients with UTIs; and (4) renal transplant patients with acute, clinically significant transplant rejection. If rejection and infection occured together, the patient's values were included with renal transplant patients with UTIs. Urine samples were obtained daily during the first hospitalization of the transplant patient and subsequently if the transplant patient developed fever, abdominal pain, or rising serum Cr levels. Urine samples were "clean-catch" specimens (23%) or sterile catheterization specimens (77%).
Each urine sample was stored on ice and centrifuged (1700 )< g for 5 mm, 4°C). Urine supernatant was isolated and stored at -80°C until analysis for nitrite, nitrate and eGMP levels. The leukocyte-rich urine sediment was processed for NOS activity and for RNA isolation.
Assay of NOS activity
The urine pellet was resuspended in ice cold PBS and centrifuged 1700 X g for five minutes [4] [5] [6] [7] . The resultant pellet was resuspended in homogenization buffer [4°C, 20 mM Hepes, pH 7.4, 1.0 mvt DTT, 0.05 m'vi PMSF, leupeptin (0.2 mgIlOO ml) and 1.0 mg/i00 ml each of soybean trypsin inhibitor, pepstatin, antipain, and chymostatin] and homogenized (10 seconds, at 70% power) using an Ultra/Turrax, T25 (IKA, Cincinnati, OH, USA). The particulate fraction of the urine pellet was washed three times with homogenization buffer and stored at -80°C until analysis. Previously, we have shown that 90% of the human iNOS activity is found in the urinary particulate fraction [4] . The assay was terminated with 1.0 ml of 20 mrvi Hepes (pH 5.5) containing 2.0 mrt EDTA. The sample was then applied to a 1.0 ml column of AG 50W-X8, Na form (Bio-Rad, Hercules, CA, USA) and eluted with 1.0 ml of Hepes (pH 5.5). The column effluent was measured in a liquid scintillation counter, after addition of 15 ml of Optifluor (Packard, Meriden, CT, USA). Thin layer chromatography of the AG 50W-X8 column effluent from the NOS activity assay showed that 88% of the radioactivity migrated as citrulline [4] . For determining NOS activity in renal transplant patients who developed rejection or infection, the significantly elevated NOS values, measured daily < three days prior to the clinical diagnosis of rejection or infection and with treatment during the patient's first hospitalization, were averaged for each patient. The NOS values for patients who returned for hospitalization with rejection or infection were measured daily and averaged for each patient. Although urine was collected daily during the patients' hospitalization, on some days there was insufficient particulate fraction for NOS analysis. The patients' average NOS activity values were summed and averaged for each disease process. Control NOS activity values were obtained from renal transplant patients who developed neither rejection nor infection during the first hospitalization. Control values were obtained daily following transplantation and were averaged.
Nitrite and nitrate levels
To determine endogenous urinary nitrite levels [4] , Griess reagent (100 p1) was added to urine (100 p1) or to sodium nitrite standards (2.9 to 58 !.tM) and incubated for 15 minutes. Nitrite was measured spectrophotometrically at 546 nm. Urinary nitrate levels were measured after reduction of nitrate to nitrite with bacterial nitrate reduetase. Nitrate standards (ito 40 1.tM) or 1:20 dilutions of urine supernatant were incubated (30 mm, 37°C) with 0.25 U/ml nitrate reductase (Sigma N7265, from Aspergillus), 250 j.tM NADPH, and 20 /kM flavin adenine dinucleotide in PBS [20] . To oxidize NADPH, 10 mM pyruvate and 10 U lactate dehydrogenase (Sigma L2500 from rabbit muscle) were added [211, the mixture was incubated for an additional 10 minutes (37°C), and the nitrite concentration was determined. Nitrate was linear over this concentration and there was a 100% conversion of nitrate to nitrite. Since this assay measures both nitrite derived from the reduction of nitrate and endogenous nitrite, endogenous nitrite levels were subtracted to determine nitrate levels.
Urine creatinine (Cr) levels were measured spectrophotometrically, using the alkaline picrate method (Sigma) [22] . Results are reported as both /kmol/liter urine and as imol/g Cr. 
RT-PCR
RNA was isolated from urinary pellets of transplant patients with infection and rejection using the Trizol reagent (Life Technologies, Inc., Gaithersburg, MD, USA). Single stranded eDNA was synthesized with oligo dT priming and Superscript Il-Reverse transeriptase (Gibco BRL, Life Technologies, Gaithersburg, MD, USA). Previous Southern blots of neutrophil-PCR products from patients with urinary tract infections detected iNOS and endothehal NOS (eNOS), but not neuronal NOS (bNOS) [61. Human iNOS specific primers did not amplify the other forms of NOS [6] . For this study, two sets of iNOS specific primers, (5'-CACCTT-TGATGAGGGGAC-3', sense) and (5'-GCATCCAGCTTGAC-CAG-3', antisense) and iNOS sense and antisense primers described by Reiling et al [23] , allowed amplification of the desired eDNA. /3-actin specific primers were used as control.
Statistical analysis
Results are expressed as mean SEM. N = the patients evaluated and n = the samples evaluated. Means are compared using the Student's t-test. Significance level is 95% for all analyses (P < 0.05).
Results

NOS activity with acute transplant rejection or with infection
Prior to transplantation, NOS activity in urinary pellets from both male and female patients with chronic renal failure was NOS activity increased to a significantly greater extent in association with bacterial UTIs than with transplant rejection. With UTIs, NOS activity increased to 29.56 11 .00 pmol citrulline/min/mg protein (N = 8; 1 to 3 samples were evaluated from each patient). With renal transplant rejection and infection, NOS activity remained elevated while the patient was hospitalized. With patient follow-up after hospitalization, the NOS values decreased to 0.18 + 0.07 pmol citrulline/min/mg protein (N = 6).
Post-operative day (Fig. 3) .
When nitrite levels were normalized using urinary Cr levels (Table 1) , patients with normal post-renal transplant function had levels of 19.9 2.5 mol/g Cr, patients with transplant rejection had levels of 22.4 3.6 imol/g Cr, and patients with infection had levels of 163 35.8 mol/g Cr. When nitrate levels were normalized using urinary Cr, nitrate levels were elevated in patients with rejection when compared to control transplant patients and transplant patients with infection, 4937 763 mol/g Cr, 1585 296 mol/g Cr, and 1900 510 itmol/g Cr, respectively.
Cyclic GMP levels were increased with transplant rejection and infection The average urinary cGMP level in control patients, individuals with good renal function, after transplantation was 0.66 0.03 .tmol cGMP/g Cr (range 0.29 to 1.2 tmol cGMP/g Cr; N = 54).
Cyclic GMP levels rose to 2.0 0.17 gmol cGMP/g Cr (range 1.2 to 3.1 .rmol cGMP/g Cr; N = 10) with rejection and to 2.5 0.36 jimol cGMP/g Cr (range 1.2 to 4.0 imol cGMP/g Cr; N = 8) with infection. We observed no significant difference in cGMP levels between transplant patients with infection or rejection. Figure 4 shows average cGMP values from seven renal transplantation RNA isolated from urine pellet of patients with infection or transplant rejection was used for RT-PCR. Using two different sets of iNOS specific primers, 413 bp and 462 bp fragments were amplified (Fig. 5) . Both primer sets amplified the human hepatocyte iNOS-cDNA but not human endothelial NOS-cDNA. DNA sequencing of both products revealed greater than 99% sequence identity to human hepatocyte iNOS.
Discussion
This study demonstrates that renal transplant rejection and infection increase human iNOS activity in the leukocyte-enriched pellet obtained from the urine of transplant patients. The increase in NOS activity occurs despite differences in the source of the transplanted kidney, cadaveric or living-related donor transplantation, or in the patient's dietary intake or administered medications. Most importantly, the increase in NOS activity occurs prior to the clinical diagnosis of rejection.
While NOS activity is elevated in the urine particulate fraction from renal transplant patients with rejection, the NOS activity is even higher in transplant patients with bacterial UTI. Previously, in bacterial infected urine from patients, iNOS was demonstrated by Western blot analysis, RT-PCR and sequencing, and immunohistochemistry of neutrophils which verified that the elevated ['4Cj-L-citrulline formation is due to iNOS activity [5, 6] .
Reasons for the differences in the magnitude of NOS activity with rejection and infection in renal transplant patients include differences in the cell populations found in the urine with the two different disease states and the presence of bacterial products, such as lipopolysaccharides, known inducers of NOS in the urine of patients with UTIs [5, 6] . Urine cytologic monitoring performed after pancreas-kidney and kidney transplantation reveals N=8 NOS activity reported is described in the Methods section. The values reported for nitrate, nitrite and cGMP levels are the peak levels measured during transplant rejection or infection. For all experiments, the control levels are from patients with a stable recovery after transplantation. N = patients evaluated and n = samples evaluated.
a Significant difference between control and rejection or infection is > 95% b Significant difference between rejection and infection is > 95% lymphocyturia with both acute rejection and UT! [24, 25] . However, despite the presence of white blood cells in urine from patients with either rejection or infection, the precent and/or activity of the cellular populations may differ and NO production from one cell type can inhibit another cell type. For instance, NO production from macrophages can inhibit lymphocyte proliferation with rat colon cancer [26] . The levels of NO oxidation-products, nitrate and nitrite, differ significantly between renal transplant patients with rejection and with infection. Urinary nitrate levels are significantly increased during renal allograft rejection and urinary nitrite levels are significantly increased in patients with urinary tract infection. While the major source of urinary nitrate is from dietary intake, endogenous biosynthesis of nitrate has been demonstrated in several human studies [27] [28] [29] . One biosynthetic pathway involves the conversion of L-arginine to NO by the enzyme nitric oxide synthase with the subsequent oxidation of NO to nitrates [27] . Because bacteria are present with infection and bacteria convert nitrate to nitrite, nitrite levels are elevated in patients with infection [30, 31] . In a previous study, we found that neither exogenous nitrate nor L-arginine increased nitrite levels in noninfected urine, but that both increased nitrite levels in infected urine [4] .
Despite the finding that NOS activity is much higher with infection than with rejection, cGMP levels are increased to the same extent with both rejection and infection. Nitric oxide activates soluble guanylyl cyclase, to stimulate the formation of cGMP [32] [33] [34] . However, other agonists, such as atrial natriuretic peptide, can activate particulate guanylyl cyclase [351. Therefore, other pathways must be considered for the elevation of urinary cGMP levels during rejection [36] . Although urinary cyclic GMP levels are elevated in transplant rejection/infection, its actions in this process are not known [81.
Therefore, we have identified an elevation of NOS activity with human renal transplant rejection and demonstrated differences in NOS activity and its products with rejection and infection in renal transplant patients. Leukocyte iNOS in urine and the oxidation products of NO may be early predictors of acute renal allograft rejection or infection and the modulation of NOS activity may be a therapeutic target [37] [38] [39] [40] . Finding an acute increase of NO in 
